Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer’s Disease
Camila Calfío, Andrea González, Sandeep Kumar Singh, et al.
Journal of Alzheimer s Disease (2020) Vol. 77, Iss. 1, pp. 33-51
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Neuroinflammation in Alzheimer’s Disease
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 209
Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
Duraisamy Kempuraj, Ramasamy Thangavel, Deepak D. Kempuraj, et al.
BioFactors (2020) Vol. 47, Iss. 2, pp. 190-197
Closed Access | Times Cited: 167
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 55
New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer’s Disease
Leonardo Guzmán‐Martínez, Camila Calfío, Gonzalo Farías, et al.
Journal of Alzheimer s Disease (2021) Vol. 82, Iss. s1, pp. S51-S63
Closed Access | Times Cited: 79
Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease
Ahsas Goyal, Aanchal Verma, Nandini Dubey, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Closed Access | Times Cited: 48
Effects of Flavonoids on Cancer, Cardiovascular and Neurodegenerative Diseases: Role of NF-κB Signaling Pathway
Maria Magdalena Barreca, Riccardo Alessandro, Chiara Corrado
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9236-9236
Open Access | Times Cited: 30
Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation
Mingming Zhang, Zhiyin Tang
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114474-114474
Open Access | Times Cited: 25
Novel Nutraceutical Compounds in Alzheimer Prevention
Ricardo B. Maccioni, Camila Calfío, Andrea González, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 249-249
Open Access | Times Cited: 35
Recent Trends and Practices Toward Assessment and Rehabilitation of Neurodegenerative Disorders: Insights From Human Gait
Ratan Das, Sudip Paul, Gajendra Kumar Mourya, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 31
Challenges in the Development of Drug Delivery Systems Based on Small Extracellular Vesicles for Therapy of Brain Diseases
Gecioni Loch-Neckel, Ana Teresa Matos, Ana Rita Vaz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
Medicine–food herb:Angelica sinensis, a potential therapeutic hope for Alzheimer's disease and related complications
Yu Long, Dan Li, Shuang Yu, et al.
Food & Function (2022) Vol. 13, Iss. 17, pp. 8783-8803
Closed Access | Times Cited: 30
Nature's toolbox against tau aggregation: An updated review of current research
Sumaiya Khan, Md. Imtaiyaz Hassan, Mohammad Shahid, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101924-101924
Closed Access | Times Cited: 22
The Effects of Pomegranate Seed Oil on Mild Cognitive Impairment
Thanos Chatzikostopoulos, Moses Gialaouzidis, Anna Koutoupa, et al.
Journal of Alzheimer s Disease (2024) Vol. 97, Iss. 4, pp. 1961-1970
Open Access | Times Cited: 8
Isolation, Structure Elucidation, Semi-Synthesis, and Structural Modification of C19-Diterpenoid Alkaloids from Aconitum apetalum and Their Neuroprotective Activities
Lin‐Xi Wan, Ji-Fa Zhang, Yongqi Zhen, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 4, pp. 1067-1077
Closed Access | Times Cited: 35
Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease
Lidia Ciccone, Jennifer Vandooren, Susanna Nencetti, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 86-86
Open Access | Times Cited: 33
Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer’s Disease
Shanshan Wang, Xianbo Kong, Zhangjing Chen, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4175-4175
Open Access | Times Cited: 23
Therapeutic Potential of Olive Leaf Extracts: A Comprehensive Review
Natália M. de Oliveira, Jorge Machado, Maria Helena Chéu, et al.
Applied Biosciences (2024) Vol. 3, Iss. 3, pp. 392-425
Open Access | Times Cited: 5
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease
Marjan Talebi, Eleni Kakouri, Mohsen Talebi, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 6, pp. 625-642
Closed Access | Times Cited: 31
Neuroinflammation in Alzheimer's disease and beneficial action of luteolin
Alejandro Delgado, Christos Cholevas, Theoharis C. Theoharides
BioFactors (2021) Vol. 47, Iss. 2, pp. 207-217
Closed Access | Times Cited: 30
Novel multi-target therapeutic potential of the genus Inula: Advances and opportunities for neuroprotection
Marjan Talebi, Mona Khoramjouy, Afsoon Feizi, et al.
Pharmacological Research - Modern Chinese Medicine (2023) Vol. 7, pp. 100263-100263
Open Access | Times Cited: 13
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
Edwin E. Reza-Zaldívar, Daniel A. Jacobo‐Velázquez
ACS Omega (2023) Vol. 8, Iss. 39, pp. 35499-35522
Open Access | Times Cited: 13
Insights into prevention mechanisms of bioactive components from healthy diets against Alzheimer's disease
Jingwen Wang, Zhi‐Ling Yu, Peng Ye, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 119, pp. 109397-109397
Open Access | Times Cited: 11
Natural compounds from herbs and nutraceuticals as glycogen synthase kinase‐3β inhibitors in Alzheimer's disease treatment
Zheng Zhao, Ye Yuan, Shuang Li, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 8
Open Access | Times Cited: 4
Pd-Catalyzed Direct Diversification of Natural Anti-Alzheimer’s Disease Drug: Synthesis and Biological Evaluation of N-Aryl Huperzine A Analogues
Shi-Xing Miao, Lin‐Xi Wan, Zhenxiang He, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 8, pp. 2374-2379
Closed Access | Times Cited: 26
Therapeutic Antiaging Strategies
Shailendra Kumar Mishra, Vyshnavy Balendra, Josephine Esposto, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2515-2515
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top